Thursday, August 3, 2017

Allergan Q2 Attributable Net Loss Widens, Lifts Revenue Guidance For FY17

Allergan plc (AGN) Thursday reported a wider net loss attributable to ordinary shareholders of $795.5 million than $571.3 million a year ago. On a per share basis, net loss were $2.37, wider than $1.44 last year. Adjusted earnings for the quarter was $3.68 billion.

from RTT - Earnings http://ift.tt/2uZCSIV
via IFTTT

No comments:

Post a Comment